相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice
Anna Rafalo-Ulinska et al.
BEHAVIOURAL BRAIN RESEARCH (2022)
Architecture and function of NMDA receptors: an evolutionary perspective
David Stroebel et al.
JOURNAL OF PHYSIOLOGY-LONDON (2021)
Cell-type specific modulation of NMDA receptors triggers antidepressant actions
Santosh Pothula et al.
MOLECULAR PSYCHIATRY (2021)
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial
Jennifer B. Dwyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Amygdala-hippocampal innervation modulates stress-induced depressive-like behaviors through AMPA receptors
Hui Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
αCaMKII in the lateral amygdala mediates PTSD-Like behaviors and NMDAR-Dependent LTD
Shuming An et al.
NEUROBIOLOGY OF STRESS (2021)
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
Elia E. Acevedo-Diaz et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression
Jennifer L. Phillips et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Structural Insights into the Regulation of Ca2+/Calmodulin-Dependent Protein Kinase II (CaMKII)
Moitrayee Bhattacharyya et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions
Danielle M. Gerhard et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The influence of ketamine's repeated treatment on brain topology does not suggest an antidepressant efficacy
Natalia Gass et al.
TRANSLATIONAL PSYCHIATRY (2020)
What ketamine can teach us about the opioid system in depression?
Laura Perez-Caballero et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Brain NMDA Receptors in Schizophrenia and Depression
Albert Adell
BIOMOLECULES (2020)
Extrasynaptic CaMKIIα is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model
Xiao-Hui Tang et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Rapid acting antidepressants in the mTOR pathway: Current evidence
K. Athira et al.
BRAIN RESEARCH BULLETIN (2020)
Estrogen Receptor alpha Agonist is Beneficial for Young Female Rats Against Chronic Unpredicted Mild Stress-Induced Depressive Behavior and Cognitive Deficits
Na Qu et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Stress-induced expression pattern of glutamate signaling genes associated with anhedonia
Nikolay N. Dygalo et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2020)
Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis
George Papakostas et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
The Emerging Role of LHb CaMKII in the Comorbidity of Depressive and Alcohol Use Disorders
Chaya Shor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial
Dawn F. Ionescu et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Stress, epigenetics and depression: A systematic review
Caroline Park et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
Lijia Chang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Augmentation effect of ketamine by guanosine in the novelty-suppressed feeding test is dependent on mTOR signaling pathway
Anderson Camargo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
S-ketamine reduces marble burying behaviour: Involvement of ventromedial orbitofrontal cortex and AMPA receptors
Cristina Luz Tosta et al.
NEUROPHARMACOLOGY (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Effects of restraint stress on the regulation of hippocampal glutamate receptor and inflammation genes in female C57BL/6 and BALB/c mice
Joshua McWhirt et al.
NEUROBIOLOGY OF STRESS (2019)
Ketamine Self-Administration Elevates αCaMKII Autophosphorylation in Mood and Reward-Related Brain Regions in Rats
Lucia Caffino et al.
MOLECULAR NEUROBIOLOGY (2018)
Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine
Chinnakkaruppan Adaikkan et al.
BIOLOGICAL PSYCHIATRY (2018)
Mechanisms of ketamine action as an antidepressant
P. Zanos et al.
MOLECULAR PSYCHIATRY (2018)
Molecular and cellular dissection of NMDA receptor subtypes as antidepressant targets
Elisabeth Lang et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Reduced Synapse and Axon Numbers in the Prefrontal Cortex of Rats Subjected to a Chronic Stress Model for Depression
David Csabai et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Enhanced Hypothalamic NMDA Receptor Activity Contributes to Hyperactivity of HPA Axis in Chronic Stress in Male Rats
Jing-Jing Zhou et al.
ENDOCRINOLOGY (2018)
Unpacking Major Depressive Disorder: From Classification to Treatment Selection
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Chronic Stress Triggers Expression of Immediate Early Genes and Differentially Affects the Expression of AMPA and NMDA Subunits in Dorsal and Ventral Hippocampus of Rats
Anibal Pacheco et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Rapid Antidepressant Effect of Hydrogen Sulfide: Evidence for Activation of mTORC1-TrkB-AMPA Receptor Pathways
Xiao-Yi Hou et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
Ashley E. Lepack et al.
NEUROPHARMACOLOGY (2016)
Changed Synaptic Plasticity in Neural Circuits of Depressive-Like and Escitalopram-Treated Rats
Xiao-Li Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
From Stress to Inflammation and Major Depressive Disorder: A Social Signal Transduction Theory of Depression
George M. Slavich et al.
PSYCHOLOGICAL BULLETIN (2014)
GluN2B-Containing NMDA Receptors Regulate Depression-Like Behavior and are Critical for the Rapid Antidepressant Actions of Ketamine
Oliver H. Miller et al.
ELIFE (2014)
βCaMKII in Lateral Habenula Mediates Core Symptoms of Depression
Kun Li et al.
SCIENCE (2013)
Role of the CaMKII/NMDA Receptor Complex in the Maintenance of Synaptic Strength
Magdalena Sanhueza et al.
JOURNAL OF NEUROSCIENCE (2011)
Measuring behavior in mice with chronic stress depression paradigm
Tatyana Strekalova et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression
S. Chourbaji et al.
FASEB JOURNAL (2008)
分享论文
